Smith Patrick W's Form 4 filing
Insight Molecular Diagnostics Inc. (IMDX) · filed Jan 15, 2025
- Accession no.
- 0001493152-25-002410
- Filed
- Jan 15, 2025
- Trade date
- Jan 13-14, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market purchases total $34.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Smith Patrick WCIK 0001167028 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 13, 2025 | Common Stock, no par value | PPurchaseAcquired | +5,669 | $2.08 | +$11,791.52 | 1,779,572 | Indirect | |
| Jan 14, 2025 | Common Stock, no par value | PPurchaseAcquired | +100 | $2.08 | +$208 | 1,779,672 | Indirect | |
| Jan 14, 2025 | Common Stock, no par value | PPurchaseAcquired | +10,286 | $2.15 | +$22,114.9 | 1,789,958 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.